ArticleScience signaling2015

Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi.

Benjamin E Housden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.